Stay updated on UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial
Sign up to get notified when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.

Latest updates to the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page
- Check7 days agoChange DetectedThe Record History now includes a new revision entry (v3.4.3) and removes the prior entry (v3.4.2).SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record history shows a new revision entry (v3.4.2) added, and older notices (including the funding lapse notice and v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedA funding-status notice was added, informing that information may not be up to date and the NIH Clinical Center is open, and the page now shows Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check49 days agoChange DetectedTerminated status was added to the study history, noting a sponsor decision, along with UI indicators such as glossary display and color-coded additions/deletions. The prior Active, not recruiting status is shown as deleted and replaced by the new status.SummaryDifference2%

- Check63 days agoChange DetectedA new revision entry (v3.3.4) was added to the page history, and the previous revision (v3.3.3) was removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page history adds a new entry Revision: v3.3.3 and removes HHS Vulnerability Disclosure along with Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.